Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Saba NF, Steuer CE, Ekpenyong A, McCook-Veal A, Magliocca K, Patel M, Schmitt NC, Stokes W, Bates JE, Rudra S, Remick J, McDonald M, Abousaud M, Tan AC, Fadlullah MZH, Chaudhary R, Muzaffar J, Kirtane K, Liu Y, Chen GZ, Shin DM, Teng Y, Chung CH.
Saba NF, et al. Among authors: mcdonald m.
Nat Med. 2024 Aug;30(8):2373. doi: 10.1038/s41591-024-03161-w.
Nat Med. 2024.
PMID: 38956200
No abstract available.